MASIMO CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 174.65 USD | +3.03% |
|
+0.26% | +49.01% |
Chart calendar Masimo Corporation
7f5ab6ffe37ae5503b49.kzDLxlHvGrlYvSpuJwgKvNiMebcwUtAhAm3Li5NMgjo.x1iYtGiCY8o98Gwrckkn9oL5SehcJYRNUS6q6ao47VXWYYm1CJdrgDviXQ~6b584782be7a9f1251f6c0541f82f50f
Upcoming events on Masimo Corporation
Past events on Masimo Corporation
| 2024-12-03 08:30 am | Piper Sandler Healthcare Conference |
| 2024-11-21 03:30 am | Jefferies London Healthcare Conference |
| 2024-11-18 11:30 am | Stifel Healthcare Conference |
| 2024-11-05 04:30 pm | Q3 2024 Earnings Call |
| 2024-11-05 04:05 pm | Q3 2024 Earnings Release |
| 2024-09-19 05:00 pm | Annual General Meeting - Proxy Fight for Board Representation |
| 2024-09-05 10:15 am | Wells Fargo Healthcare Conference |
| 2024-08-06 04:30 pm | Q2 2024 Earnings Call |
| 2024-08-06 04:05 pm | Q2 2024 Earnings Release |
| 2024-07-25 05:00 pm | Annual General Meeting |
| 2024-06-12 08:00 am | Goldman Sachs Global Healthcare Conference |
| 2024-06-05 01:00 pm | Jefferies Global Healthcare Conference |
| 2024-05-15 07:20 pm | BofA Securities Health Care Conference |
| 2024-05-07 04:30 pm | Q1 2024 Earnings Call |
| 2024-05-07 04:05 pm | Q1 2024 Earnings Release |
| 2024-03-05 03:25 pm | Raymond James Institutional Investors Conference |
| 2024-02-27 04:30 pm | Q4 2023 Earnings Call |
| 2024-02-27 04:05 pm | Q4 2023 Earnings Release |
| 2023-11-29 09:30 am | Piper Sandler Healthcare Conference |
| 2023-11-15 10:00 am | Jefferies London Healthcare Conference |
Past dividends on Masimo Corporation
| 2012-11-22 | 1 USD |
| 2010-12-02 | 0.75 USD |
| 2010-03-08 | 2 USD |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1 239 1 232 0.55% | 2 036 2 021 0.71% | 2 048 2 045 0.17% | 2 087 | 2 220 | 2 365 |
|
EBITDA Million USD | Released Forecast Spread | 330 327 1.2% | 498 415 19.97% | 411 348 18.35% | 386 | 437 | 479 |
|
EBIT Million USD | Released Forecast Spread | 295 291 1.44% | 362 354 2.33% | 313 302 3.74% | 332 | 378 | 422 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 274 283 -3.08% | 193 243 -20.31% | 88,1 103 -14.82% | 139 | 255 | 314 |
|
Net income Million USD | Released Forecast Spread | 230 223 2.77% | 144 149 -3.44% | 81,5 78,1 4.41% | 94,7 | 188 | 239 |
|
EPS USD | Released Forecast Spread | 3,98 3,87 2.85% | 2,60 2,69 -3.4% | 1,51 1,43 5.7% | 1,74 | 3,48 | 4,28 |
| Announcement Date | 15/02/22 | 28/02/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | Septiembre | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 565 558 1.28% | 455 468 -2.65% | 479 499 -3.99% | 549 546 0.59% | 493 488 1.04% | 496 494 0.49% | 505 503 0.35% | 592 | 525 | 529 | 534 | 626 | 550 | 557 | 558 |
|
EBITDA Million USD | Released Forecast Spread | 102 93,1 9.16% | 83,8 74,1 13.09% | 81,4 79,0 3.03% | 114 95,7 19.33% | 92,2 88,1 4.61% | 91,8 84,6 8.46% | 96,8 82,7 17.06% | 127 | 96,4 | 92,1 | 87,5 | 129 | |||
|
EBIT Million USD | Released Forecast Spread | 75,5 73,6 2.51% | 58,6 59,4 -1.36% | 56,9 55,7 2.12% | 91,7 80,6 13.76% | 67,9 65,0 4.47% | 72,9 68,9 5.78% | 80,8 71,5 12.97% | 110 | 86,9 | 87,2 | 89,8 | 115 | 90,3 | 91,9 | 96,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 26,2 32,6 -19.63% | 24,8 39,4 -37.04% | 14,0 24,0 -41.69% | 23,2 38,4 -39.54% | 24,9 25,9 -3.75% | 19,9 21,1 -5.49% | 11,6 33,6 -65.49% | 82,2 | 64,2 | 61,8 | 72,3 | 92,4 | |||
|
Net income Million USD | Released Forecast Spread | 21,3 27,4 -22.24% | 15,7 15,6 0.68% | 10,6 16,1 -34.09% | 34,0 30,6 11.09% | 18,9 18,5 2.25% | 16,0 14,1 13.63% | 9,80 16,0 -38.58% | 49,9 | 42,9 | 42,0 | 44,2 | 63,6 | |||
|
EPS USD | Released Forecast Spread | 0,39 0,50 -22.26% | 0,29 0,28 2.11% | 0,20 0,29 -31.82% | 0,63 0,56 12.17% | 0,35 0,34 2.51% | 0,29 0,26 12.26% | 0,18 0,29 -38.29% | 0,91 | 0,79 | 0,76 | 0,79 | 1,14 | |||
| Announcement Date | 09/05/23 | 08/08/23 | 07/11/23 | 27/02/24 | 07/05/24 | 06/08/24 | 05/11/24 | - | - | - | - | - | - | - | - |
| 2025-01-28 02:00 am | GETINGE AB: Q4 2024 Earnings Release |
| 2025-02-04 | CHEMOMETEC A/S: Q2 2025 Earnings Release |
| 2025-02-11 | ASAHI INTECC CO., LTD.: Q2 2025 Earnings Release (Projected) |
| 2025-02-14 02:00 am | IMPLANTICA AG: Q4 2024 Earnings Release |
| 2025-02-19 | NOVOCURE LIMITED: Q4 2024 Earnings Release (Projected) |
| 2025-02-24 | PENUMBRA, INC.: Q4 2024 Earnings Release (Projected) |
| 2025-02-25 | ZIMVIE INC.: Q4 2024 Earnings Release (Projected) |
| 2025-03-02 | SI-BONE, INC.: Q4 2024 Earnings Release (Projected) |
| 2025-03-03 | INARI MEDICAL, INC.: Q4 2024 Earnings Release (Projected) |
| 2025-03-03 | MASIMO CORPORATION: Q4 2024 Earnings Release (Projected) |
Past sector events for Masimo Corporation
| 2024-11-15 02:00 am | IMPLANTICA AG: Q3 2024 Earnings Release |
| 2024-11-13 | ASAHI INTECC CO., LTD.: Q1 2025 Earnings Release |
| 2024-11-12 04:09 pm | SI-BONE, INC.: Q3 2024 Earnings Release |
| 2024-11-07 11:12 am | CHEMOMETEC A/S: Q1 2025 Sales and Revenue Release - Trading Statement |
| 2024-11-05 04:05 pm | MASIMO CORPORATION: Q3 2024 Earnings Release |
| 2024-10-30 | SHANDONG WEIGAO ORTHOPAEDIC DEVICE CO., LTD: Q3 2024 Earnings Release |
| 2024-10-30 04:05 pm | PENUMBRA, INC.: Q3 2024 Earnings Release |
| 2024-10-30 07:00 am | NOVOCURE LIMITED: Q3 2024 Earnings Release |
| 2024-10-29 | SHENZHEN YHLO BIOTECH CO., LTD.: Q3 2024 Earnings Release |
| 2024-10-28 | SHANGHAI SANYOU MEDICAL CO., LTD: Q3 2024 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MASI Stock
- Calendar Masimo Corporation